Emory University
1,806
253
329
1,081
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
15.4%
279 terminated/withdrawn out of 1806 trials
79.5%
-7.0% vs industry average
14%
245 trials in Phase 3/4
49%
534 of 1081 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1806)
Arginine Replacement Therapy in COVID-19
Role: lead
H5N1 Milk Detection Study
Role: lead
Reboot Pain (tDCS)
Role: lead
Tailored Electronic Intervention to Improve Therapy in a Diverse Cohort of Patients With Heart Failure
Role: lead
Thrive With Type 1 Diabetes 2026
Role: lead
A Human Challenge Study to Assess Protection of a Shigella Tetravalent Bioconjugate Vaccine
Role: collaborator
MDMA-Assisted Massed Exposure Therapy for PTSD
Role: lead
Effects of Stimulation Patterns of Deep Brain Stimulation
Role: collaborator
Function of Tamsulosin in Older Males Undergoing Surgery With Indwelling Catheter
Role: lead
Low Dose Naltrexone for Pain in Patients With HIV
Role: lead
Non-Invasive Diagnostic Tests for MASLD in Pediatric Population
Role: lead
Safety and Tolerability Trial of Psilocybin in Healthy Older Adults
Role: collaborator
Genetic Information for Families After Tumor Testing Study
Role: collaborator
Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity
Role: lead
Biomarker-Driven Radiation Therapy Dose Reduction After Transoral Robotic Surgery for the Treatment of HPV-Positive Oropharyngeal Cancer
Role: lead
Parrying the Pitfalls of PrEP: Project PEACH
Role: lead
Heart Rate Variability and Inflammatory Bowel Disease
Role: lead
Melatonin's Effect on Nighttime Blood Pressure and Sleep in OSA Patients (MEBP-OSA)
Role: collaborator
Improving Status Epilepticus Treatment Times
Role: collaborator
Meningococcal Serogroup ACYWX Conjugate Vaccine in Comparison With MenACWY-TT Conjugate Vaccine
Role: lead